IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protalix Biotherapeutics Inc

CUSIP: 74365AAD3 | 11 institutional holders

Quarters

Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2021

Highbridge Capital Management LLC15,000,000
0.1% of portfolio›$15.8K
Angelo Gordon & Co., L.P.1,397,000
0.0% of portfolio›$1.4K
Ingalls & Snyder LLC500,000
0.0% of portfolio›$512
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Highbridge Capital Management LLC
15,000,000$15.8K0.1%ValueVery HighNew York, NY2021-11-12
Angelo Gordon & Co., L.P.
1,397,000$1.4K0.0%GARPMediumNew York, NY2021-11-15
Ingalls & Snyder LLC
500,000$5120.0%CoreVery LowNew York, NY2021-10-27
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2021-11-09